Role of Enterotoxin on YAP Activation in Colonic Sessile Serrated Adenoma/ Polyps with Dysplasia
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Sessile serrated adenoma/polyp with dysplasia (SSA/P-D) is an SSA/P with cellular dysplasia and has a higher risk of progressing to colon carcinogenesis. Previously, we reported that tight junction impairment by enterotoxin (CPE) leads to activation of the transcriptional co-activator yes-associated protein (YAP) in oral squamous cell carcinoma. Here, we investigated whether CPE activates YAP to promote the malignant progression of SSA/P. E-cadherin expression was lower in the 12 cases with SSA/P-D examined than that in normal mucosa, SSA/P, or tubular adenoma (TA). Furthermore, intracellular translocation of claudin-4 (CLDN4) and nuclear translocation of YAP were observed. The CPE gene was detected in DNA extracted from SSA/P-D lesions, but not in SSA/P or TA. Treatment of the rat intestinal epithelial cell line IEC6 with low-dose CPE resulted in intracellular translocation of CLDN4 to the cytoplasmic membrane. Cytoplasmic CLDN4 showed co-precipitation with transcriptional co-activator with PDZ-binding motif, zonula occludens (ZO)-1, large tumor suppressor, and mammalian Ste20-like. Additionally, YAP co-precipitated with ZO-2 under CPE treatment led to decreased YAP phosphorylation and nuclear translocation. YAP activation promoted increase in nuclear TEA domain family member level, expression of cyclin D1, snail, vimentin, CD44, NS and decrease in E-cadherin levels, thereby inducing stemness and epithelial-mesenchymal-transition (EMT). The Hippo complex with the incorporation of CLDN4 increased stability. Upon low-dose CPE treatment, HT29 cells with BRAF gene mutation showed increased growth, enhanced invasive potential, stemness, and induced EMT phenotype, whereas HCT116 cells, which carry KRAS gene mutation, did not show such changes. In an examination of 10 colorectal cancers, an increase in EMT and stemness was observed in CPE (+) and BRAF mutation (+) cases. These findings suggest that might enhance the malignant transformation of SSA/P-D via YAP activation. Our findings further highlight the importance of controlling intestinal flora using probiotics or antibiotics.
Jeon H, Sterpi M, Mo C, Bteich F Front Oncol. 2024; 14:1454882.
PMID: 39391254 PMC: 11464258. DOI: 10.3389/fonc.2024.1454882.
Functional links between the microbiome and the molecular pathways of colorectal carcinogenesis.
Permain J, Hock B, Eglinton T, Purcell R Cancer Metastasis Rev. 2024; 43(4):1463-1474.
PMID: 39340753 PMC: 11554747. DOI: 10.1007/s10555-024-10215-5.
The role of the gut microbiota in tumor, immunity, and immunotherapy.
Xie Y, Liu F Front Immunol. 2024; 15:1410928.
PMID: 38903520 PMC: 11188355. DOI: 10.3389/fimmu.2024.1410928.
Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer.
Schiavoni G, Messina B, Scalera S, Memeo L, Colarossi C, Mare M J Transl Med. 2024; 22(1):213.
PMID: 38424512 PMC: 10903154. DOI: 10.1186/s12967-024-05027-8.
Gyoten M, Luo Y, Fujiwara-Tani R, Mori S, Ogata R, Kishi S Int J Mol Sci. 2023; 24(23).
PMID: 38069135 PMC: 10706654. DOI: 10.3390/ijms242316814.